PDF herunterladen
Synthesis 2005(15): 2562-2570  
DOI: 10.1055/s-2005-872110
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis and Wagner-Meerwein Rearrangement of 9-(α-Hydroxyalkyl)xanthenes to 10-Substituted Dibenz[b,f]oxepins: Scope, Limitations and ab initio Calculations

Thomas Storz*a, Eric Vangrevelingheb, Peter Dittmara
a Process R&D, Chemical & Analytical Development, Novartis Pharma AG, 4002 Basel, Switzerland
b Computer-Aided Molecular Design Unit, Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland
Fax: +1(805)3754532; e-Mail: tstorz@amgen.com;
Weitere Informationen

Publikationsverlauf

Received 27 February 2005
Publikationsdatum:
04. August 2005 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

A series of 9-(hydroxy)alkyl xanthenes 5 was prepared in good yields via: (a) addition of 9-lithioxanthene to functionalized acetaldehydes, or, via a new method, (b) addition of carbanions to xanthene-9-carbaldehyde. A practical and efficient synthesis was found for the latter. Under acidic catalysis, the majority of the addition products underwent Wagner-Meerwein rearrangement to give either the corresponding, 10-substituted dibenz[b,f]oxepin 6 or the xanthenylid-9-ene β-elimination product 7. The first Wagner-Meerwein rearrangement of a homobenzylic cyanohydrin is reported. The dibenz[b,f]oxepins are potential precursors of neuroactive substances. To rationalize product distribution, and probe the scope of the new rearrangement, ab initio quantum mechanical calculations have been carried out on products and transition states in selected cases.

Key words

Wagner-Meerwein rearrangement - dibenz[b,f]oxepin - 9-hydroxyalkyl-xanthene - dehydration - β-elimination - transition state stability

    References

  • 2 Burke ER. Kholodilov NG. Ann. Neurol.  1998,  44:  126 
    CrossrefGoogle Scholar
  • 3a Zimmermann K. Waldmeier PC. Tatton WG. Pure Appl. Chem.  1999,  71:  2039 
    Google Scholar
  • 3b Mück-eler D. Pivac N. IDrugs  2000,  3:  530 
    Google Scholar
  • 3c Cloos PAC, Jensen FR, Boissy P, and Stahlhut M. inventors; WO  2004039773, A20513. 
  • 4a Waldmeier PC. Boulton AA. Cools AR. Kato AC. Tatton WG. Adv. Res. Neurodegen.  2000,  8:  197 
    CrossrefGoogle Scholar
  • 4b Sagot Y. Toni N. Perrelet D. Lurot S. King B. Rixner H. Mattenberger L. Waldmeier PC. Kato AC. Br. J. Pharmacol.  2000,  131:  721 
    CrossrefGoogle Scholar
  • 4c LeWitt PA. Neurology  2004,  63:  S23 
    CrossrefGoogle Scholar
  • 5a Olivera R. SanMartin R. Churruca F. Dominguez E. J. Org. Chem.  2002,  67:  7215 
    Google Scholar
  • 5b SanMartin R. Olivera R. Churruca F. Tellitu I. Dominguez E. Trends Heterocycl. Chem.  2003,  9:  259 
    Google Scholar
  • 6 Bischoff S. In Novel Antipsychotic Drugs   Meltzer; New York: 1992.  p.117-134  
    Google Scholar
  • 7a Mercep M, Mesic M, and Pesic D. inventors; PCT Int. Appl., WO  2003099822, 20031204. 
    Crossref
  • 7b Kiyama R. Honma T. Hayashi K. Ogawa M. Hara M. Fujimoto M. Fujishita T. J. Med. Chem.  1995,  38:  2728 
    CrossrefGoogle Scholar
  • 7c Lambrou GN, Latour E, and Waldmeier P. inventors; WO  2004066993, A10812. 
    Crossref
  • 8a Zimmermann K. Roggo S. Kragten E. Fürst P. Waldmeier P. Bioorg. Med. Chem. Lett.  1998,  8:  1195 
    CrossrefPubMedGoogle Scholar
  • 8b Kanno S, and Okita T. inventors; JP  2000044568, A20215. 
    CrossrefPubMed
  • 8c Arnold LA. Wenchen L. Guy RK. Org. Lett.  2004,  6:  3005 
    CrossrefPubMedGoogle Scholar
  • 9 Tosylate 8: Anet FAL. Bavin PMG. Can. J. Chem.  1957,  35:  1081 . In this work, sulfonate esters of the parent alcohols 5a-m were not investigated as starting materials for the Wagner-Meerwein rearrangement
    Google Scholar
  • 10 Other authors reproduced this reaction in boiling benzene and found 85% yield of dibenz[b,f]oxepin: Hess BA. Bailey AS. Bartusek B. Boekelheide V. J. Am. Chem. Soc.  1969,  91:  1665 
    CrossrefGoogle Scholar
  • 11a

    Smith Kline & French patent; US 3100207, 1963; claims a more lengthy approach to 10-aminomethyldibenz[b,f]oxe­-pins via 9-hydroxymethyl-9-aminoalkylxanthenes.

    Google Scholar
  • 11b Bergmann and Rabinovitz claimed the rearrangement of 9-(α-hydroxybenzyl)xanthene (5d) to 10-phenyldibenz-[b,f]oxepin but proof of structure was tentative (only IR, mp given): Bergmann D. Rabinovitz M. Isr. J. Chem.  1963,  1:  125 
    Google Scholar
  • In our hands, the substrate 5d did not rearrange, but rather gave the β-elimination product (7d, Table 1), in accordance with the theoretical calculations (vide supra, Table 3).
  • 11c Xanthene pKHA[THF] = 31.4: Fraser RR. Mansour TS. Savard S. J. Org. Chem.  1985,  50:  3232 
    Google Scholar
  • 11d The 9-lithiation of xanthene was originally reported by Nakai et al.: Nakai R. Sugii M. Tomono H. Bull. Inst. Chem. Res., Kyoto Univ.  1955,  33:  211 
    Google Scholar
  • It was also reported by Mahesh et al.:
  • 11e Mahesh VB. Seshadri TR. J. Sci. Ind. Res., Sect. B  1955,  14:  608 
    Google Scholar
  • 12 Only one other, more cumbersome method of preparation for this aldehyde (careful DIBAL-reduction of xanthene-9-carbonyl chloride) has been reported: Rochlin E. Rappoport Z. J. Am. Chem. Soc.  1992,  114:  230.  In our hands, this procedure gave mostly xanthone after aqueous workup and silica gel chromatography of the crude product
    CrossrefGoogle Scholar
  • 15 Reichardt C. Solvents and Solvent Effects in Organic Chemistry   VCH-Wiley; Weinheim, N.Y.: 1988.  p.140ff 
    Google Scholar
  • 16 Jaguar 5.5   Schrödinger, LLC; Portland, OR: 1991-2003. 
    Google Scholar
  • 17 Szabo A. Ostlund NS. Modern Quantum Chemistry, Introduction to Advanced Electronic Structure Theory   MacMillan; New York: 1982. 
    Google Scholar
  • 18 Koch W. Holthausen MC. A Chemist’s Guide to Density Functional Theory   John Wiley and Sons; New York: 2001. 
    Google Scholar
  • 19 Pachuau Z. Lyngdoh D. J. Chem. Sci.  2004,  116:  83 
    CrossrefGoogle Scholar
  • The putative spirocyclopropyl cyclohexadienyl transition state dates back to the pioneering work of Winstein et al., where this transition state had been invoked to rationalize rates of solvolysis and alkyl group migration in substituted, primary phenethyl tosylates and related systems; compare:
  • 20a Winstein S. Lindegren CR. Marshall H. Ingraham LL. J. Am. Chem. Soc.  1953,  75:  147 
    CrossrefGoogle Scholar
  • 20b Denney DB. Goldstein B. J. Am. Chem. Soc.  1957,  79:  4948 
    CrossrefGoogle Scholar
  • 20c Winstein S. Fainberg AH. J. Am. Chem. Soc.  1958,  80:  459 
    CrossrefGoogle Scholar
  • 20d Raber DJ. Harris JM. Schleyer PVR. J. Am. Chem. Soc.  1971,  93:  4829 
    CrossrefGoogle Scholar
  • 20e Loupy A. Seyden-Penne J. Tetrahedron  1973,  29:  1015 
    CrossrefGoogle Scholar
1

Current address: Amgen Inc., One Amgen Center Drive, P. O. Box, Thousand Oaks, CA 91320-1799, USA.

13

Typical procedure (5k): To a solution of xanthene 3 (3.64 g, 20 mmol) in anhyd THF (60 mL) under Ar at -65 °C was added n-BuLi (1.1 equiv, 8.1 mL, 2.7 M solution in n-heptane). After stirring at -65 °C for 30 min, a fine red suspension formed. Ethyl formate (1.77 g, 24 mmol) in THF (12 mL) was added dropwise at -65 °C. Stirring at -60 °C to -70 °C for 3 h resulted in a clear, orange solution. After HPLC had indicated complete conversion of 3, glacial AcOH (1.32 g, 22 mmol) was added slowly, such that the temperature did not exceed -60 °C. To the resulting yellowish solution of 4 Huenig’s base (3.1 g, 24 mmol), followed by nitromethane (1.46 g, 24 mmol) were added. The turbid mixture was warmed to r.t. overnight. After quenching with aq AcOH and adjusting the pH to neutral, extraction with CH2Cl2 and purification of the crude product by silica gel chromatography afforded 5k (4.63 g, 85%) as a slightly yellowish solid. Similarly were prepared: 5i [KCN (1.0 equiv), -40 °C to r.t., no base, 91% yield), and 5j [ HPO(OEt)2 (1.1 equiv), -40 °C to r.t., Huenig’s base (1.2 equiv), 91% yield].

14

For substrates obtained using method B, it is best to avoid workup and isolation (see ref. 12), and instead use the in situ-prepared aldehyde(4) solution (see ref. 13) directly in the next step.